Exchange: NASDAQ·Updated 07:30 PM EDT
PRQR logo

PRQR ProQR Therapeutics N.V

$2.09
$0.06
(2.79%)
Today
Closed $2.09
$0.04
(1.91%)
After Hours

About PRQR

ProQR Therapeutics NV is a clinical stage biopharmaceutical company, which engages in the discovery and development of RNA therapies for the treatment of severe genetic rare diseases with a focus on inherited retinal diseases. The company was founded by Daniel Anton de Boer, Gerard J. Platenburg, Henri A. Termeer, and Domenico Valerio on February 21, 2012, and is headquartered in Leiden, the Netherlands.
Loading...

Fundamentals

Mkt Cap
$296.89M
52W High
$3.10
52W Low
$1.33
PE Ratio
-4.51
Avg. Volume
986,937.52
EPS (Annual)
-$0.452
Earnings
Aug 13
36

Bearish Sentiment

How do you feel about PRQR?

Advertisement|Remove ads.